Development of a new high efficiency method for drug delivery using nanoparticles and liquid precursor in Atmospheric Pressure Plasma Enhanced Vapour Deposition (AP-PECVD) processr application in theranostics

Emerging as a targeted, safe and efficient pharmacotherapy is the approach of theranostics, which focuses on patient-centered care. It is a combination of diagnosis and therapeutics and provides a cost-effective specific successful treatment protocol. The aim of this research would be to take all the knowledge that has been gathered during the previous 2 years of study of nanoparticle and polymer deposition using atmospheric pressure plasma. It has been concluded that nanocomposites can be created, the next step will be to evaluate the cabability of the method to deposit two types of nanoparticles at the same time. This will create nanocomposites, which will contain particles responsible for drug delivery as well as imaging agents, allowing dual performance: therapy and diagnosis. In order to create the dual-application nanocomposites a careful analysis of not only the deposition itself, but also the process itself as it happens. To do that a unique configuration for Space-Resolved Fourier Transform Infrared Spectroscopy, which is one of this kind in the world, was built in Perpignan, France.

Faculty Supervisor:

Gaétan Laroche

Student:

Partner:

Université de Perpignan

Discipline:

Engineering

Sector:

Education

University:

Université Laval

Program: